This website is an independent initiative of the historic and founding shareholders of OSE Immunotherapeutics. It is not the company's corporate website. Its purpose is to inform other shareholders and stakeholders about our positions and proposals in the context of the debate on strategy and governance.

If you would like more information about the 2025 General Assembly, or any other request, please do not hesitate to contact us.

Write to us

Please feel free to contact us directly by email by clicking here, or by filling out the contact form below.

Contact Presse

For journalists only:
Contact severine[at]mrsbesse.com

    Close